Table 8.
Comparison of NPS in published studies.
| Study | Year | Country | Tumor types | Sample | Survival |
|---|---|---|---|---|---|
| Galizia | (11) | Italy | colorectal cancer | 562 | OS,DFS |
| Miyamoto | (12) | Japan | colorectal cancer | 259 | OS |
| Galizia | (16) | Italy | gastric cancer | 415 | OS,DFS |
| Li | (13) | China | endometrial cancer | 1038 | OS,PFS |
| Yang | (15) | China | osteosarcoma | 133 | OS,PFS |
| Nakagawa | (17) | Japan | pancreatic cancer | 196 | OS |
| Li | (14) | China | lung Cancer | 457 | OS,DFS |
| Kano | (18) | Japan | ESCC | 165 | RFS, OS |
| Current | 2021 | China | ESCC | 287 | CSS |
ESCC, esophageal squamous cell carcinoma; NPS, Naples prognostic score; OS, overall survival; DFS, disease-free survival; PFS, progression-free survival; RFS, recurrence-free survival; CSS, cancer-specific survival.